| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VACCINEX, INC. | SVP, Research & CSO | Stock Option (Right to Buy) | 1,341 | $5,310 | $3.96 | 21 Mar 2024 | Direct |
| VACCINEX, INC. | SVP, Research & CSO | Common Stock | 39 | $28 | $0.7250 | 20 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VCNX | VACCINEX, INC. | 21 Mar 2024 | 1 | $0 | 4/A | SVP, Research & CSO | 14 May 2024, 16:36 |
| VCNX | VACCINEX, INC. | 20 Mar 2024 | 1 | $0 | 4 | SVP, Research & CSO | 22 Mar 2024, 16:32 |
| VCNX | VACCINEX, INC. | 31 Mar 2023 | 1 | $0 | 4 | SVP, Research & CSO | 03 Apr 2023, 16:33 |
| VCNX | VACCINEX, INC. | 01 Apr 2022 | 1 | $0 | 4 | SVP, Research & CSO | 04 Apr 2022, 16:37 |